Epidural Versus Continuous Wound Ropivacaine Infusion Analgesia

National and Kapodistrian University of Athens

Status: Completed

Conditions: Postoperative Analgesia

Treatments: Other: Epidural analgesia; Other: Continuous wound infusion

Study type: Interventional

Funder types: Other

Identifiers

NCT01916473

M-20/23-02-2010

Details and patient eligibility

About

Study Hypothesis: The analgesic requirements and pain scores postoperatively differ between the epidural and continuous wound infusion techniques.

Full description

The analgesic requirements and pain scores postoperatively differ between the epidural and continuous wound infusion techniques, in patients undergoing myomectomy or hysterectomy.

Enrollment: 80 patients

Sex: Female

Ages: 25 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Patients ASA I-II scheduled for abdominal hysterectomy or myomectomy -

Exclusion criteria

Age older than 60 and younger than 25 years, body weight exceeding the 30% of the ideal, consumption of analgesics, sedatives, anxiolytics, antidepressants, calcium channel blockers, CNS disease or insulin dependent diabetes

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

80 participants in 2 patient groups

Epidural analgesia

Active Comparator group

Description:

Epidural analgesia is provided with ropvacaine 0.2% given 6 hourly

Treatment:

Other: Epidural analgesia

Continuous wound infusion

Experimental group

Description:

The continuous wound infusion consists of 0.376% ropivacaine infusion in the wound area at a rate 2 ml per hour.

Treatment:

Other: Continuous wound infusion